SCHEMBL7146891

SCHEMBL7146891

COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)n2n[c]nc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NTRK1 P04629 2/20 0.41
PIM1 P11309 2/20 0.41
ACVR1 Q04771 1/20 0.41
CASP1 P29466 2/20 0.38
KDM4E B2RXH2 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
MAP4K4 O95819 1/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7144535 0.91 NTRK1 (0.40) NTRK1PIM1ACVR1TUBB4ATUBB
SCHEMBL7043074 0.91 NTRK1 (0.45) NTRK1PIM1CASP1KDM4EMEN1
SCHEMBL7041861 0.89 IKBKB (0.46) NTRK1PIM1KDM4EMEN1KMT2A
SCHEMBL7143148 0.88 NTRK1 (0.34) NTRK1PIM1ACVR1CASP1KDM4E
SCHEMBL7146568 0.88 IKBKB (0.38) KDM4EMEN1KMT2ATUBB4ATUBB
SCHEMBL7148119 0.83 IKBKB (0.38) KDM4EMEN1KMT2ATUBB4ATUBB
SCHEMBL7043840 0.83 PARP1 (0.43) KDM4ELMNASMN1; SMN2IKBKBMAPT
SCHEMBL6875678 0.83 IKBKB (0.35) KDM4EMEN1KMT2ATUBB4ATUBB
SCHEMBL7145673 0.83 TLR8 (0.48) TUBB4ATUBBTUBA3CTUBA1BTUBA4A
SCHEMBL7046810 0.82 KDM4E (0.34) CASP1KDM4EMEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6514989-B1 Has a good affinity to the adenosine receptor and can therefore be used for the treatment or protection of diseases mediated by this receptor HOFFMANN-LA ROCHE INC. 2003-02-04 US disclosed